{"brief_title": "Study of Licarbazepine in the Treatment of Manic Episodes of Bipolar Disorder", "brief_summary": "This purpose of this study is to evaluate the safety and efficacy of Licarbazepine for the treatment of manic episodes of bipolar disorder.", "condition": ["Bipolar Disorder"], "intervention_type": ["Drug"], "intervention_name": ["Licarbazepine"], "criteria": "Inclusion Criteria: - Diagnosis of bipolar disorder (type I) with manic or mixed episodes (including patients with/without psychotic features or with/without a history of rapid cycling) - In need of psychiatric treatment - Cooperation and willingness to complete all aspects of the study Exclusion Criteria: - Current diagnosis other than bipolar I disorder - History of schizophrenia or schizoaffective disorder - Drug dependence within 1 month prior to study start or testing positive in a urine drug test - Suicide attempt within 1 month prior to study start or at immediate risk of harm to self or others - Any form of psychotherapy within 1 month prior to study start", "gender": "All", "minimum_age": "18 Years", "maximum_age": "70 Years", "healthy_volunteers": "No", "keyword": "licarbazepine", "mesh_term": ["Disease", "Bipolar Disorder"], "id": "NCT00099229"}